CSPC Pharmaceutical’s SYS6010 gets Breakthrough Therapy designation
CSPC Pharmaceutical said SYS6010 was granted Breakthrough Therapy designation by the NMPA.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CSPC Pharmaceutical said SYS6010 was granted Breakthrough Therapy designation by the NMPA.